BioCentury
ARTICLE | Company News

Epigenomics, Predictive Biosciences sales and marketing update

February 4, 2013 8:00 AM UTC

The partners said Predictive Biosciences launched a biopsy test to diagnose prostate cancer in the U.S. that incorporates Epigenomics' glutathione S-transferase pi 1 ( GSTP1) DNA methylation marker. ...